Published in Ann Intern Med on July 15, 1992
Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother (1993) 5.96
Vancomycin-resistant enterococci. Clin Microbiol Rev (2000) 5.61
Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis (1998) 4.84
Virulence of enterococci. Clin Microbiol Rev (1994) 4.32
Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J Clin Microbiol (1993) 4.25
Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol (1994) 3.61
Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother (1996) 3.48
Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother (1994) 3.02
Current perspectives on glycopeptide resistance. Clin Microbiol Rev (1995) 2.99
Hospital-acquired infections: diseases with increasingly limited therapies. Proc Natl Acad Sci U S A (1994) 2.87
Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol (1993) 2.59
A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci. Antimicrob Agents Chemother (1993) 2.56
Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis. Antimicrob Agents Chemother (1994) 2.43
Detection of vancomycin-resistant enterococci in fecal samples by PCR. J Clin Microbiol (1997) 2.32
Relationships between enterococcal virulence and antimicrobial resistance. Clin Microbiol Rev (2000) 2.27
Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother (1995) 2.14
Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev (1997) 1.94
Use of cephalexin-aztreonam-arabinose agar for selective isolation of Enterococcus faecium. J Clin Microbiol (1994) 1.85
Diversity among multidrug-resistant enterococci. Emerg Infect Dis (1998) 1.83
Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis (2002) 1.77
Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother (2002) 1.71
A PCR assay for identification of Enterococcus faecium. J Clin Microbiol (1997) 1.61
Identification and characterization of multiple species of vancomycin-resistant enterococci, including an evaluation of Vitek software version 7.1. J Clin Microbiol (1993) 1.52
Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. J Clin Microbiol (1996) 1.43
Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium. Antimicrob Agents Chemother (1994) 1.33
Survival of vancomycin-resistant and vancomycin-susceptible enterococci on dry surfaces. J Clin Microbiol (1998) 1.25
Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital. J Clin Microbiol (1997) 1.25
Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis. Antimicrob Agents Chemother (2000) 1.08
Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrob Agents Chemother (1993) 1.05
The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment. Ther Adv Infect Dis (2014) 0.99
Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusetts. J Clin Microbiol (1998) 0.98
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium. Antimicrob Agents Chemother (1993) 0.95
Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin-resistant Enterococcus faecalis isolates. J Clin Microbiol (1996) 0.94
Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob Agents Chemother (1996) 0.94
Activity of clinafloxacin against multidrug-resistant Enterococcus faecium. Antimicrob Agents Chemother (1994) 0.93
Effective cohorting and "superisolation" in a single intensive care unit in response to an outbreak of diverse multi-drug-resistant organisms. Surg Infect (Larchmt) (2011) 0.92
Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital. J Clin Microbiol (1994) 0.91
Persistence of microbial communities including Pseudomonas aeruginosa in a hospital environment: a potential health hazard. BMC Microbiol (2014) 0.91
Comparison of the Rodac imprint method to selective enrichment broth for recovery of vancomycin-resistant enterococci and drug-resistant Enterobacteriaceae from environmental surfaces. J Clin Microbiol (2000) 0.88
Increasing Antimicrobial Resistance: Therapeutic Implications for Enterococcal Infections. Curr Infect Dis Rep (2000) 0.86
Contamination of the clinical microbiology laboratory with vancomycin-resistant enterococci and multidrug- resistant Enterobacteriaceae: implications for hospital and laboratory workers. J Clin Microbiol (2001) 0.85
Adhesive tape and intravascular-catheter-associated infections. J Gen Intern Med (1999) 0.85
APSIC Guidelines for environmental cleaning and decontamination. Antimicrob Resist Infect Control (2015) 0.82
Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period. J Clin Microbiol (1999) 0.81
Enterococcus faecium in hospitals. Eur J Clin Microbiol Infect Dis (1997) 0.81
Rapid curbing of a vancomycin-resistant Enterococcus faecium outbreak in a nephrology department. Clin J Am Soc Nephrol (2009) 0.81
Identification of vancomycin-resistant enterococci clones and inter-hospital spread during an outbreak in Taiwan. BMC Infect Dis (2013) 0.81
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients. West J Med (1998) 0.80
Engineering infection control through facility design. Emerg Infect Dis (2001) 0.80
Temporal Artery versus Bladder Thermometry during Adult Medical-Surgical Intensive Care Monitoring: An Observational Study. BMC Anesthesiol (2010) 0.80
Heat tolerance of vancomycin resistant Enterococcus faecium. J Clin Pathol (1996) 0.78
Antimicrobial susceptibilities of enterococci isolated from hospitalized patients. Antimicrob Agents Chemother (1993) 0.78
Microorganisms in Confined Habitats: Microbial Monitoring and Control of Intensive Care Units, Operating Rooms, Cleanrooms and the International Space Station. Front Microbiol (2016) 0.76
Electronic thermometers and nosocomial infections. Ann Intern Med (1993) 0.75
Electronic thermometers and nosocomial infections. Ann Intern Med (1993) 0.75
Treatment of enterococcal pyelonephritis with trovafloxacin and rifampin: in vitro-in vivo contrast. Antimicrob Agents Chemother (1998) 0.75
Bacterial contamination of stethoscopes. J Family Community Med (2004) 0.75
Prevention and control of infections in the home. CMAJ (2009) 0.75
Evaluation of Susceptibility of Glycopeptide-resistant and Glycopeptide-sensitive Enterococci to Commonly Used Biocides in a Super-speciality Hospital: A Pilot Study. J Nat Sci Biol Med (2017) 0.75
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med (2001) 9.53
A comparison of pre-operative nerve stimulator-guided femoral nerve block and fascia iliaca compartment block in patients with a femoral neck fracture. Anaesthesia (2013) 6.65
Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med (1986) 5.84
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet (2009) 5.68
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Studies on the bacteremia of bacterial endocarditis. JAMA (1967) 5.00
Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med (1970) 4.93
Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med (1998) 4.81
Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev (1999) 4.63
Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc Natl Acad Sci U S A (1986) 4.43
Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science (2006) 4.23
Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum. J Virol (1979) 3.81
Antibiotic synergism in enterococcal endocarditis. J Lab Clin Med (1976) 3.79
Structural aspects of the p53 protein in relation to gene evolution. Oncogene (1990) 3.64
Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet (1992) 3.60
Rat model of experimental endocarditis. Infect Immun (1978) 3.48
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1973) 3.45
Comparison of two beta-lactamase-producing strains of Streptococcus faecalis. Antimicrob Agents Chemother (1986) 3.33
Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res (2001) 3.30
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med (2001) 3.25
Cardiovascular risk factors in British children from towns with widely differing adult cardiovascular mortality. BMJ (1996) 3.14
Organization and sequences of the variable, joining and constant region genes of the human T-cell receptor alpha-chain. Nature (1985) 3.08
High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Ann Intern Med (1989) 3.02
Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry (1996) 2.99
The rhythm of the normal human heart. Lancet (1976) 2.94
Thiamin biosynthesis in prokaryotes. Arch Microbiol (1999) 2.91
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med (1983) 2.91
Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy (2007) 2.88
Sensitive system for visualising biotinylated DNA probes hybridised in situ: rapid sex determination of intact cells. J Clin Pathol (1985) 2.84
The Huntington's disease candidate region exhibits many different haplotypes. Nat Genet (1992) 2.84
Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A (1995) 2.80
Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers. Antimicrob Agents Chemother (1980) 2.65
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst (1995) 2.64
A simplifying concept in tumor virology: virus-specific "pleiotropic effectors". Cold Spring Harb Symp Quant Biol (1975) 2.61
Pharmacology of cefazolin in patients with normal and abnormal renal function. J Infect Dis (1973) 2.49
Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility. Arch Intern Med (1982) 2.49
Daptomycin (LY146032) treatment of experimental enterococcal endocarditis. Antimicrob Agents Chemother (1988) 2.47
Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science (1983) 2.47
Translational and rotational diffusion constants of tobacco mosaic virus from Rayleigh linewidths. Biophys J (1969) 2.38
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Protamine is an inhibitor of angiogenesis. Nature (1982) 2.30
Adherence of Candida albicans to human vaginal and buccal epithelial cells. J Infect Dis (1981) 2.27
p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol (1993) 2.27
Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53. Oncogene (1987) 2.26
Double-blind controlled comparison of phlebitis produced by cephapirin and cephalothin. Antimicrob Agents Chemother (1973) 2.26
Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women? Ann Intern Med (1994) 2.26
In vitro evaluation of tobramycin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother (1972) 2.18
beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis. J Infect Dis (1987) 2.17
Serious infections caused by diphtheroids. Ann N Y Acad Sci (1970) 2.15
The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. JAMA (2000) 2.12
Observer variation in the detection of colorectal neoplasia on double-contrast barium enema: implications for colorectal cancer screening and training. Clin Radiol (2003) 2.12
Photosynthetic Carbon Fixation in Guard Cell Protoplasts of Vicia faba L. : Evidence from Radiolabel Experiments. Plant Physiol (1988) 2.12
Twenty-four-hour intragastric pH patterns in ICU patients on ranitidine. Dig Dis Sci (1992) 2.04
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer. Ann Oncol (2007) 2.03
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA (1989) 2.03
DNA polymorphisms among Escherichia coli isolated from bacteriuric women. J Infect Dis (1989) 2.02
Airway obstruction with percutaneous tracheostomy. Chest (1997) 2.02
Quantitative bacteriology of the vaginal flora in vaginitis. Am J Obstet Gynecol (1979) 2.02
Attentive novelty detection in humans is governed by pre-attentive sensory memory. Nature (1994) 2.02
The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function. J Infect Dis (1974) 2.00
Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology (1997) 1.99
The experience of a department of medicine with a clinical medical library service. J Med Educ (1985) 1.97
Serum lipids in infection. N Engl J Med (1969) 1.93
Groin hernia repair in Scotland. Br J Surg (2000) 1.93
Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics. Antimicrob Agents Chemother (1980) 1.92
Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. Clin Infect Dis (2011) 1.92
Identification of a diversity segment of human T-cell receptor beta-chain, and comparison with the analogous murine element. Nature (1984) 1.92
Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control. JAMA (2000) 1.88
Antibacterial activity of human urine. J Clin Invest (1968) 1.86
Quantitative microflora of the vagina. Am J Obstet Gynecol (1977) 1.86
Lack of association between bacteriuria and symptoms in the elderly. Am J Med (1986) 1.85
Health and exposures of United Kingdom Gulf war veterans. Part I: The pattern and extent of ill health. Occup Environ Med (2001) 1.84
The solitary thyroid nodule--benign or malignant. Praxis (1967) 1.81
Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic. JAMA (1969) 1.80
Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic. Antimicrob Agents Chemother (1972) 1.80
Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod (1998) 1.80
Changes in cross-sectional measurements of the spinal canal and intervertebral foramina as a function of body position: in vivo studies on an open-configuration MR system. AJR Am J Roentgenol (1999) 1.79
Lead and protein content of isolated intranuclear inclusion bodies from kidneys of lead-poisoned rats. Lab Invest (1970) 1.77
Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1986) 1.74
Alcohol control and injury death in Alaska native communities: wet, damp and dry under Alaska's local option law. J Stud Alcohol (2000) 1.73
Muscular contraction: kinetics of crossbridge attachment studied by high-frequency stiffness measurements. Science (1982) 1.71
Microbiological agar diffusion assay for metronidazole concentrations in serum. Antimicrob Agents Chemother (1974) 1.70
Light chain 2 profile and activity of human ventricular myosin during dilated cardiomyopathy. Identification of a causal agent for impaired myocardial function. Circulation (1992) 1.70
Mapping the transcription site of the SV40-specific late 16 S mRNA. Nucleic Acids Res (1975) 1.68